Concord Medical Services
7 hedge funds and large institutions have $1.37M invested in Concord Medical Services in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
250% more funds holding
Funds holding: 2 → 7 (+5)
50% more capital invested
Capital invested by funds: $915K → $1.37M (+$457K)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$113K |
| 2 |
CAL
Capital Analysts LLC
Fort Washington,
Pennsylvania
|
+$3.01K |
| 3 |
BlackRock
New York
|
+$1.87K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$845 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$735 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$34.2K |
CCM Hedge Fund Activity: Q1 2021 in Review
7 of the 5,710 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q1 2021, worth a combined $1.37M — up 50% from $915K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CCM positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $113K. The largest seller was Renaissance Technologies, cutting an estimated $34.2K.
- 7 institutional investors held Concord Medical Services (CCM) as of Q1 2021, up from 2 in Q4 2020.
- Funds reported $1.37M of Concord Medical Services stock for Q1 2021, up 50% quarter-over-quarter.
- 6 funds opened new Concord Medical Services positions in Q1 2021 and 0 closed out, a net change of +6 holders.
- The largest Concord Medical Services buyer in Q1 2021 was Citadel Advisors, an estimated $113K added.
- The largest Concord Medical Services seller in Q1 2021 was Renaissance Technologies, an estimated $34.2K sold.
Based on aggregated 13F filings for Q1 2021.